Search research articles
Contact Us
Filters
Showing results (11-20 of 44) with videos related to
Page
of 5
Sort By:
Bioorganic & Medicinal Chemistry Letters
|
June 24, 2000
Cytotoxic alpha-bromoacrylic derivatives of distamycin analogues modified at the amidino moiety
P Cozzi, I Beria, M Caldarelli, et al.
Biochemical Pharmacology
|
December 1, 1988
Intracellular doxorubicin concentrations and drug-induced DNA damage in a human colon adenocarcinoma cell line and in a drug-resistant subline
M Broggini, M Grandi, P Ubezio, et al.
Journal of Cancer Research and Clinical Oncology
|
January 1, 1989
Cellular and molecular pharmacology of 4'-epidoxorubicin in HeLa cells. Comparison with its parent drug, doxorubicin
O Cantoni, P Sestili, F Cattabeni, et al.
Tumori
|
December 31, 1981
Biologic activity of daunorubicin linked to proteins via the methylketone side chain
F Zunino, R Gambetta, A Vigevani, et al.
Bioorganic & Medicinal Chemistry
|
April 28, 1999
Novel benzoyl nitrogen mustard derivatives of pyrazole analogues of distamycin A: synthesis and antileukemic activity
P G Baraldi, P Cozzi, C Geroni, et al.
Cancer Research
|
March 31, 2001
4-Demethoxy-3'-deamino-3'-aziridinyl-4'-methylsulphonyl-daunorubicin (PNU-159548), a novel anticancer agent active against tumor cell lines with different resistance mechanisms
S Marchini, G Damia, M Broggini, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 11, 2000
Phenyl sulfur mustard derivatives of distamycin A
P Cozzi, I Beria, M Caldarelli, et al.
British Journal of Cancer
|
December 1, 1995
Decreased tyrosine phosphorylation in tumour cells resistant to FCE 24517 (tallimustine)
M Ciomei, W Pastori, L Capolongo, et al.
Cancer Research
|
June 24, 2000
In vivo antitumor activity and host toxicity of methoxymorpholinyl doxorubicin: role of cytochrome P450 3A
L Quintieri, A Rosato, E Napoli, et al.
Cancer Research
|
January 1, 1991
Selective DNA interaction of the novel distamycin derivative FCE 24517
M Broggini, E Erba, M Ponti, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 44) with videos related to
Sort By:
Page
of 5
Bioorganic & Medicinal Chemistry Letters
|
June 24, 2000
Cytotoxic alpha-bromoacrylic derivatives of distamycin analogues modified at the amidino moiety
P Cozzi, I Beria, M Caldarelli, et al.
Biochemical Pharmacology
|
December 1, 1988
Intracellular doxorubicin concentrations and drug-induced DNA damage in a human colon adenocarcinoma cell line and in a drug-resistant subline
M Broggini, M Grandi, P Ubezio, et al.
Journal of Cancer Research and Clinical Oncology
|
January 1, 1989
Cellular and molecular pharmacology of 4'-epidoxorubicin in HeLa cells. Comparison with its parent drug, doxorubicin
O Cantoni, P Sestili, F Cattabeni, et al.
Tumori
|
December 31, 1981
Biologic activity of daunorubicin linked to proteins via the methylketone side chain
F Zunino, R Gambetta, A Vigevani, et al.
Bioorganic & Medicinal Chemistry
|
April 28, 1999
Novel benzoyl nitrogen mustard derivatives of pyrazole analogues of distamycin A: synthesis and antileukemic activity
P G Baraldi, P Cozzi, C Geroni, et al.
Cancer Research
|
March 31, 2001
4-Demethoxy-3'-deamino-3'-aziridinyl-4'-methylsulphonyl-daunorubicin (PNU-159548), a novel anticancer agent active against tumor cell lines with different resistance mechanisms
S Marchini, G Damia, M Broggini, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 11, 2000
Phenyl sulfur mustard derivatives of distamycin A
P Cozzi, I Beria, M Caldarelli, et al.
British Journal of Cancer
|
December 1, 1995
Decreased tyrosine phosphorylation in tumour cells resistant to FCE 24517 (tallimustine)
M Ciomei, W Pastori, L Capolongo, et al.
Cancer Research
|
June 24, 2000
In vivo antitumor activity and host toxicity of methoxymorpholinyl doxorubicin: role of cytochrome P450 3A
L Quintieri, A Rosato, E Napoli, et al.
Cancer Research
|
January 1, 1991
Selective DNA interaction of the novel distamycin derivative FCE 24517
M Broggini, E Erba, M Ponti, et al.
Page
of 5